biguanides has been researched along with Malignant Melanoma in 1 studies
Biguanides: Derivatives of biguanide (the structure formula HN(C(NH)NH2)2) that are primarily used as oral HYPOGLYCEMIC AGENTS for the treatment of DIABETES MELLITUS, TYPE 2 and PREDIABETES.
biguanides : A class of oral hypoglycemic drugs used for diabetes mellitus or prediabetes treatment. They have a structure based on the 2-carbamimidoylguanidine skeleton.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, Y | 1 |
| Yang, M | 1 |
| Ji, Q | 1 |
| Fan, D | 1 |
| Peng, H | 1 |
| Yang, C | 1 |
| Xiong, D | 1 |
| Zhou, Y | 1 |
1 other study available for biguanides and Malignant Melanoma
| Article | Year |
|---|---|
Anoikis induction and metastasis suppression by a new integrin αvβ3 inhibitor in human melanoma cell line M21.
Topics: Animals; Anoikis; Antineoplastic Agents; Biguanides; Caspases; Cell Adhesion; Cell Line, Tumor; Dise | 2011 |